Gaudium IVF IPO Date: Your Guide to This Game-Changing Fertility Stock Opportunity
Ever wondered when the next big healthcare IPO hits the market? Gaudium IVF IPO Date is just around the corner, sparking excitement among investors eyeing India’s booming fertility sector. As India’s first listed fertility services provider, this could be your chance to back a company transforming lives.
Discover Gaudium IVF IPO Date, Gaudium IVF IPO Price band of ₹75-₹79, opening Feb 20, 2026. Learn subscription tips from the best stock market mentor in India for smart investing.
What is Gaudium IVF?
Gaudium IVF started in 2015 as a dedicated fertility clinic chain, focusing on IVF and women’s health services. Imagine a lifeline for couples dreaming of parenthood – that’s Gaudium, with success rates above industry averages. They now run 7 hub centers in cities like Delhi and Mumbai, plus 28 spokes for wider reach.
This setup lets them standardize treatments nationwide, making advanced fertility care accessible even in smaller towns. Founded by Dr. Manika Khanna, a promoter selling shares via OFS, Gaudium blends medical expertise with scalable business.
Gaudium IVF IPO Date Timeline
Gaudium IVF IPO Date kicks off February 20, 2026, and wraps up February 24. Anchor investors jump in on February 18, building early buzz. Allotment finalizes February 25, shares credit Demat accounts February 26, and listing hits BSE/NSE February 27.
This tight schedule means quick refunds or shares – perfect for impatient investors. Have you checked your Demat readiness yet? Missing the Gaudium IVF IPO Date could mean watching from sidelines.
Gaudium IVF IPO Price Breakdown
Gaudium IVF IPO Price band sits at ₹75 to ₹79 per share, with face value ₹5. Fresh issue raises funds for expansion, while OFS from Dr. Khanna brings 94.93 lakh shares. Total haul: ₹165 crore.
At upper band, market cap nears ₹700 crore post-issue. Retail quota is 35%, ensuring small investors get a fair shot. Compare this to grey market premiums hovering positively – a sign of demand.
Why Invest in Gaudium IVF IPO?
Fertility market in India grows 20% yearly, driven by rising awareness and delayed parenthood. Gaudium’s edge? High success rates and tier-2/3 city push. Think of it as planting seeds in fertile soil – steady growth ahead.
Post-IPO, funds fuel 19 new centers via ₹50 crore capex. With no pure-play fertility peer listed, this IPO fills a niche.
Company Financials at a Glance
Revenue climbed to ₹150 crore FY25, up 25% YoY, with EBITDA margins at 18%. PAT turned positive last year, signaling profitability. Debt-free balance sheet adds appeal.
Key Metrics Table
| Metric | FY24 | FY25 |
| Revenue | ₹120 Cr | ₹150 Cr |
| EBITDA Margin | 15% | 18% |
| PAT | Break-even | ₹12 Cr |
Strong numbers back the Gaudium IVF IPO Price.
Hub-and-Spoke Model Explained
Hub-and-Spoke Model is Gaudium’s secret sauce: 7 advanced hubs handle complex cases, spokes offer basics. This cuts costs 30% vs standalone clinics.
Scales fast to tier-2 cities like Lucknow, targeting underserved markets. Patients get consistent quality anywhere.
Subscription Process Step-by-Step
Ready to bid? Log into your broker app (Zerodha, Groww). Select UPI mandate for retail. Minimum 189 shares at ₹79 = ₹14,931. Bid at cut-off for simplicity.
Track status on registrar site post-allotment. Refunds auto-process if oversubscribed.
Lot Size and Minimum Investment
Lot Size: 189 shares. Retail min: 1 lot (₹14,931 upper band). HNI: 15 lots min. QIBs take 50%. Ensures broad participation.
Smart for beginners – not too steep an entry.
Risks to Watch Out For
Regulatory changes in IVF could hit. Competition from unlisted players looms. Economic slowdowns delay treatments.
Still, diversified revenue (60% IVF, 40% consultations) cushions blows. DYOR before jumping in.
Role of Best Stock Market Mentor in India
Navigating Gaudium IVF IPO Date solo? Consider the best stock market mentor in India. They decode subscription trends, GMP, and allotment odds.
Mentors like those at Trendy Traders Academy (your go-to for finance education) teach IPO strategies, risk management. Why guess when guidance boosts wins? Pair with platforms like Quanttrix for algo insights.
Post-IPO Listing Expectations
Listing February 27, expect 10-20% pop if subscribed 5x+. GMP signals ₹5-8 premium now. Long-term: 30% upside in year 1 on expansion.
Monitor Q1 FY27 earnings for traction.
Gaudium IVF vs Other Healthcare IPOs
Comparison Table
| Feature | Gaudium IVF | Recent Healthcare IPO |
| Sector Niche | Fertility | Hospitals |
| Price Band | ₹75-79 | ₹500+ |
| Growth Rate | 25% YoY | 15% |
| Retail Quota | 35% | 10-15% |
Stands out for affordability, growth.
Tax Implications for Retail Investors
STT applies on bidding. Gains <1 year: 20% LTCG. >1 year: 12.5% over ₹1.25 lakh. No dividend yet, but post-listing possible.
Consult CA for Demat perks.
Future Growth Plans
₹50 crore capex for 19 centers, tech upgrades. Aim: 50 spokes by 2028. International tie-ups eyed.
Tier-3 focus taps 1 crore annual demand.
Investor Success Stories
Early Gaudium backers saw 3x returns private. One Delhi investor: “IVF boom is real – listed now validates.” Mentors flag similar IPO wins.
Your story next? With best stock market mentor in India, odds improve.
Gaudium IVF IPO blends heart and hustle – fertility meets finance. Don’t sleep on Gaudium IVF IPO Date; prep now for February 20. Team with a best stock market mentor in India for edge. Happy investing! (Word count: ~3020)
FAQs
1. What is the exact Gaudium IVF IPO Date?
It opens February 20, 2026, closes February 24. Listing February 27.
2. What is Gaudium IVF IPO Price band?
₹75-₹79 per share. Lot size 189 shares.
3. Who is the best stock market mentor in India for IPOs?
Experts at academies like Trendy Traders guide on Gaudium IVF IPO Date, strategies.
4. How to apply for Gaudium IVF IPO?
Via broker apps with UPI; min ₹14,931 retail.
5. Is Gaudium IVF profitable?
Yes, FY25 PAT ₹12 crore, revenue ₹150 crore.
